title: The COPD Pipeline XIV.
authors.affiliation: St. Francis Hospital, Hartford, CT, USA.
authors.forename: Nicholas J
authors.initials: NJ
authors.lastname: Gross
mesh_terms: D002986:Clinical Trials as Topic; D004338:Drug Combinations; D004983:Ethanolamines / Q000627:therapeutic use; D005112:Extracorporeal Circulation / Q000295:instrumentation; D020868:Gene Silencing; D006801:Humans; D007546:Isoquinolines / Q000627:therapeutic use; D000068758:Mometasone Furoate, Formoterol Fumarate Drug Combination; D010726:Phosphodiesterase Inhibitors / Q000627:therapeutic use; D011244:Pregnadienediols / Q000627:therapeutic use; D029424:Pulmonary Disease, Chronic Obstructive / Q000188:drug therapy*; D011744:Pyrimidinones / Q000627:therapeutic use; D034741:RNA, Small Interfering / Q000627:therapeutic use; D054390:Receptors, CCR2 / Q000037:antagonists & inhibitors; D061485:Tobacco Use Cessation Devices
chemical_list: D004338:Drug Combinations; D004983:Ethanolamines; D007546:Isoquinolines; D000068758:Mometasone Furoate, Formoterol Fumarate Drug Combination; D010726:Phosphodiesterase Inhibitors; D011244:Pregnadienediols; D011744:Pyrimidinones; D034741:RNA, Small Interfering; D054390:Receptors, CCR2; C512996:ensifentrine